Clinical Trial: Cardiovascular Safety of Atomoxetine in Children With ADHD

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858448) titled 'Cardiovascular Safety of Atomoxetine in Children With ADHD' on Sept. 29.

Brief Summary: This prospective observational cohort study aims to evaluate the cardiovascular safety of atomoxetine therapy in children with attention-deficit/hyperactivity disorder during the first six months of treatment.

Study Start Date: Sept. 30

Study Type: OBSERVATIONAL

Condition: Attention Deficit Hyperactivity Disorder

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Aya Abdelwarith Sayed, Assiut University

Disclaimer: Curated by HT Syndication....